Evidence map›Paper›PMID 35169058›Full record

ArticleThe Journal of rheumatology2022

PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjögren Syndrome.

Dana D DiRenzo, Susan Robinson, Clifton O Bingham, Alan N Baer, Thomas Grader-Beck

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dana D DiRenzoD.D. DiRenzo, MD, MHS, S. Robinson, MS, C.O. Bingham III, MD, A.N. Baer, MD, T. Grader-Beck, MD, The Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0001-9350-1821
Susan RobinsonD.D. DiRenzo, MD, MHS, S. Robinson, MS, C.O. Bingham III, MD, A.N. Baer, MD, T. Grader-Beck, MD, The Johns Hopkins University, Baltimore, Maryland, USA.
Clifton O BinghamD.D. DiRenzo, MD, MHS, S. Robinson, MS, C.O. Bingham III, MD, A.N. Baer, MD, T. Grader-Beck, MD, The Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0002-4752-5029
Alan N BaerD.D. DiRenzo, MD, MHS, S. Robinson, MS, C.O. Bingham III, MD, A.N. Baer, MD, T. Grader-Beck, MD, The Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0001-8344-013X
Thomas Grader-BeckD.D. DiRenzo, MD, MHS, S. Robinson, MS, C.O. Bingham III, MD, A.N. Baer, MD, T. Grader-Beck, MD, The Johns Hopkins University, Baltimore, Maryland, USA.

Funding

Sample Processing and Immunoassay Research CoreP30AR070254 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CLIFTON O BINGHAM, Antony Rosen · 2016 to 2026
$8.9M
NIAMS NIH HHS P30 AR070254
6 · The paper itself

Abstract

objectiveSjögren syndrome (SS) has a significant impact on health-related quality of life (HRQOL). We sought to evaluate how the Patient Reported Outcome Measurement Information System (PROMIS) domains in SS may supplement the European League Against Rheumatism (EULAR) Sjögren Syndrome Patient Reported Index (ESSPRI).

methodsA cross-sectional evaluation was performed on consecutive adult patients during visits to an SS clinic between March 2018 and February 2020. Each patient completed PROMIS short forms related to HRQOL and the ESSPRI, and had a clinical assessment. Patients were either classified as SS by 2016 American College of Rheumatology (ACR)/EULAR criteria, or as "sicca not otherwise specified (NOS)" and used as a comparison group. Univariable and multivariable linear regression models were used to evaluate predictors of PROMIS fatigue (-F), pain interference (-PI), and ability to participate in social roles and activities (-APS).

resultsTwo hundred twenty-seven patients with SS and 85 with sicca NOS were included and did not differ in ESSPRI domains; 26% of the SS and 20% of the sicca NOS group had concurrent autoimmune disease. In SS, PROMIS-PI, PROMIS-F, and PROMIS physical function were at least one-half SD worse than US population normative values. PROMIS-PI (

conclusionIn our SS cohort, PROMIS instruments identified a high disease burden of pain interference, fatigue, and physical function. PROMIS-F strongly predicted PROMIS-APS. PROMIS-PI and PROMIS-F scores correlated highly with their respective ESSPRI domains. PROMIS instruments should be considered to identify relevant HRQOL patterns in SS.

Indexed as

Sjogren's SyndromeAdultCross-Sectional StudiesFatigueHumansInformation SystemsPainPatient Reported Outcome MeasuresQuality of LifeESSPRIfatiguehealth-related quality of lifePROMISSjögren syndrome

Identifiers

PMID35169058
PMCPMC9522433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.